Fiona McGill1, Michael J Griffiths, Tom Solomon. 1. aInstitute of Infection and Global Health, University of Liverpool bNational Institute for Health Research Health Protection Research Unit on Emerging and Zoonotic Infections, University of Liverpool cRoyal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool dLeeds Teaching Hospitals NHS Trust, Leeds eAlderhey Children's NHS Foundation Trust fThe Walton Centre NHS Foundation Trust, Liverpool, UK.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to give an overview of viral meningitis and then focus in on some of the areas of uncertainty in diagnostics, treatment and outcome. RECENT FINDINGS: Bacterial meningitis has been declining in incidence over recent years. Over a similar time period molecular diagnostics have increasingly been used. Because of both of these developments viral meningitis is becoming relatively more important. However, there are still many unanswered questions. Despite improvements in diagnostics many laboratories do not use molecular methods and even when they are used many cases still remain without a proven viral aetiology identified. There are also no established treatments for viral meningitis and the one potential treatment, aciclovir, which is effective in vitro for herpes simplex virus, has never been subjected to a clinical trial. SUMMARY: Viruses are in increasingly important cause of meningitis in the era of declining bacterial disease. The exact viral aetiology varies according to age and country. Molecular diagnostics can not only improve the rate of pathogen detection but also reduce unnecessary antibiotics use and length of hospitalization. Further research is required into treatments for viral meningitis and the impact in terms of longer term sequelae.
PURPOSE OF REVIEW: The purpose of this review is to give an overview of viral meningitis and then focus in on some of the areas of uncertainty in diagnostics, treatment and outcome. RECENT FINDINGS: Bacterial meningitis has been declining in incidence over recent years. Over a similar time period molecular diagnostics have increasingly been used. Because of both of these developments viral meningitis is becoming relatively more important. However, there are still many unanswered questions. Despite improvements in diagnostics many laboratories do not use molecular methods and even when they are used many cases still remain without a proven viral aetiology identified. There are also no established treatments for viral meningitis and the one potential treatment, aciclovir, which is effective in vitro for herpes simplex virus, has never been subjected to a clinical trial. SUMMARY: Viruses are in increasingly important cause of meningitis in the era of declining bacterial disease. The exact viral aetiology varies according to age and country. Molecular diagnostics can not only improve the rate of pathogen detection but also reduce unnecessary antibiotics use and length of hospitalization. Further research is required into treatments for viral meningitis and the impact in terms of longer term sequelae.
Authors: Sarah D Torres; Dan Tong Jia; Emily M Schorr; Brian L Park; Alexandra Boubour; Amelia Boehme; Jyoti V Ankam; Jacqueline S Gofshteyn; Charles Tyshkov; Daniel A Green; Wendy Vargas; Jason Zucker; Anusha K Yeshokumar; Kiran T Thakur Journal: J Neurovirol Date: 2019-09-16 Impact factor: 2.643
Authors: Dara Petel; Michelle Barton; Christian Renaud; Lynda Ouchenir; Jason Brophy; Jennifer Bowes; Sarah Khan; Ari Bitnun; Jane McDonald; Andrée-Anne Boisvert; Joseph Ting; Ashley Roberts; Joan L Robinson Journal: BMC Pediatr Date: 2020-05-26 Impact factor: 2.125
Authors: Abdolkarim Ghadimi Moghadam; Eslam Yousefi; Mohamad Amin Ghatie; Ali Ghadimi Moghadam; Gholam Reza Pouladfar; Marzieh Jamalidoust Journal: J Family Med Prim Care Date: 2020-03-26
Authors: A Pormohammad; S Lashkarbolouki; T Azimi; P Gholizadeh; N Bostanghadiri; H Safari; S Armin; N Mohtavinejad; F Fallah Journal: New Microbes New Infect Date: 2019-08-29
Authors: Julia Derk; Hannah E Jones; Christina Como; Bradley Pawlikowski; Julie A Siegenthaler Journal: Front Cell Neurosci Date: 2021-07-01 Impact factor: 5.505
Authors: Stephanie A Bannister; Stephen P Kidd; Elizabeth Kirby; Sonal Shah; Anvy Thomas; Richard Vipond; Michael J Elmore; Andrew Telfer Brunton; Peter Marsh; Steve Green; Nigel J Silman; Karen E Kempsell Journal: High Throughput Date: 2018-10-16